M&A Deal Summary

Lantheus Medical Imaging Acquires Progenics Pharmaceuticals

On October 2, 2019, Lantheus Medical Imaging acquired life science company Progenics Pharmaceuticals

Acquisition Highlights
  • This is Lantheus Medical Imaging’s 1st transaction in the Life Science sector.
  • This is Lantheus Medical Imaging’s 1st transaction in the United States.
  • This is Lantheus Medical Imaging’s 1st transaction in New York.

M&A Deal Summary
Date 2019-10-02
Target Progenics Pharmaceuticals
Sector Life Science
Buyer(s) Lantheus Medical Imaging
Deal Type Add-on Acquisition
Advisor(s) Jefferies (Financial)
O'Melveny & Myers (Legal)

Target

Progenics Pharmaceuticals

Tarrytown, New York, United States
Progenics Pharmaceuticals, Inc. is a pharmaceutical company provides medicines to treat disease, focusing on cancer and related conditions with a pipeline that includes product candidates in preclinical through late-stage development. Progenics Pharmaceuticals was founded in 1986 and is based in New York City, New York.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Lantheus Medical Imaging

North Billerica, Massachusetts, United States
Category Company
Founded 1956
Sector Medical Products
Employees612
Revenue 425M USD (2021)
DESCRIPTION

Lantheus Medical Imaging is a supplier of radiopharmaceuticals and contrast agents for nuclear and ultrasound-based cardiovascular diagnostic imaging procedures. Lantheus Medical Imaging was founded in 1956 and is based in North Billerica, Massachusetts.

DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 3
State (New York) 1 of 1
Country (United States) 1 of 3
Year (2019) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-03 Lantheus Puerto Rico Radiopharmacy and PET Manufacturing Facility

San Juan, Puerto Rico

Lantheus' Puerto Rico Radiopharmacy and PET Manufacturing Facility include both the Lantheus radiopharmacy and PMF businesses located in San Juan, Puerto Rico. The radiopharmacy prepares individual, patient-ready doses of radiopharmaceuticals, and the PMF manufactures the drug product for individual, patient-ready doses of fluorodeoxyglucose (FDG).

Sell $18M
Mergr

Product

Company

Legal